Pingora Partners’s BioCardia BCDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$149K Buy
120,382
+84,643
+237% +$89.3K 0.09% 90
2026
Q1
$43.2K Buy
35,739
+32,703
+1,077% +$40.9K 0.03% 135
2025
Q4
$3.79K Buy
3,036
+2,000
+193% +$2.72K ﹤0.01% 197
2025
Q3
$1.34K Hold
1,036
﹤0.01% 198
2025
Q2
$2.02K Hold
1,036
﹤0.01% 200
2025
Q1
$2.63K Hold
1,036
﹤0.01% 202
2024
Q4
$2.26K Hold
1,036
﹤0.01% 220
2024
Q3
$3.23K Hold
1,036
﹤0.01% 216
2024
Q2
$3.08K Sell
1,036
-4
-0.4% -$20 ﹤0.01% 225
2024
Q1
$6.35K Buy
1,040
+546
+111% +$3.91K ﹤0.01% 233
2023
Q4
$4.93K Buy
+494
New +$4.01K ﹤0.01% 151

Other funds holding BCDA

Pingora Partners's BCDA Position: Q2 2026 in Review

Pingora Partners increased its BioCardia (BCDA) stake by 237% in Q2 2026, buying an estimated $89.3K and bringing the position to 120,382 shares worth $149K. The position accounts for 0.09% of the portfolio, ranked #90.

Pingora Partners first reported a position in BCDA in Q4 2023 and has held it in 11 quarters since. 21 funds tracked by Wall St. Rank hold BCDA as of Q2 2026.

  • Pingora Partners held 120,382 shares of BioCardia worth $149K as of Q2 2026.
  • Pingora Partners bought 84,643 BioCardia shares in Q2 2026, an estimated $89.3K.
  • BioCardia made up 0.09% of Pingora Partners's portfolio in Q2 2026, its #90 holding.
  • Pingora Partners first reported a position in BioCardia in Q4 2023 and has held it in 11 quarters since.
  • 21 funds tracked by Wall St. Rank held BioCardia as of Q2 2026.

Based on Pingora Partners's 13F filing for Q2 2026, filed 14 Aug 2026.